search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Pharmaceutical & medical


and have set URS, functionality specification and validation documentation methodologies that they follow from beginning to end. Conversely, the other segment needs more handholding throughout the entire process. They may be entering new markets and consequently ask for everything. Even features that are not needed. As impartial yet experienced medical


consultants, Sumitomo (SHI) Demag can customise support to complement in-house resources. This can include adapting tried and tested documentation blueprints to scope out URS, artwork design, software and functional specifications. These files all have transportable sections, which can be tailored to each medical application a machine is being commissioned for.


  





WHAT ADVICE CAN YOU OFFER TO HELP STREAMLINE DOCUMENTATION PROCESSES? There are no Qualification or Validation shortcuts. And with no standardised GMP documentation formats to follow, there are always subtle style differences. Yet, it is good practice to keep this documentation as tight as possible, ensuring the content is unambiguous. Detailed but of a manageable size, without deviating from the original design qualification. Medical manufacturers that create their own


 


GMP documentations benefit from having a consistent tool to track the qualification of all associated equipment, including mould tools and automation solutions. This makes it much easier to manage defined steps for design, installation, operational and production Qualifications and Validations.


WHY IS THERE SUCH AN EMPHASIS ON DOCUMENTATION? Predominantly due to the liability risks. Legally, customers cannot hold the machinery suppliers liable. So, understandably, those who take on the task of bringing products to market want to ‘cover their backs’ legally. Resulting in a lot of written requirements being sourced from suppliers. In our experience, European customers fall


into one of two camps. Those that are highly competent in GMP qualification and validation


WHY ARE PRELIMINARY DEFINITIONS SO CRITICAL? It may seem blindingly obvious, but you cannot test or validate against something that has not been defined at the outset. The URS underpins the design qualification. Listing every element, the assigned authorised expert must state that every requirement can be fulfilled or present an alternative option. Without the URS, you cannot progress to GMP documentation. The URS is always used by our engineers to


define the machine layout. Medical customers use it for Validation, verifying that the injection moulding machine is equipped as defined at the preliminary stage and is working as expected. Customers that cannot determine their needs


can always draw upon our pool of medical experts to populate a document with the design detail. This consultancy support gives a level of transparency to all parties, helping to circumvent renegotiations later down the project line. Having a defined structure also enhances the overall production quality. It is a real value-added service.


Prior to installation, Sumitomo (SHI) Demag issues Qualification GMP documentation, assuring customers that the equipment sold meets the defined parameters specified in the URS, design and functional specifications


Instrumentation Monthly January 2023


HOW IS GMP QUALIFICATION DOCUMENTATION DELIVERED? It is a large paperwork file despatched with every medical injection moulding machine. The signatures are of great importance. How the GMP documentation is signed and dated is


tightly regulated, even down to the preferred ink used. Even if all the documentation is correct, if the signature requirements have not been adhered to, e.g. someone else has signed on your behalf, the Qualification documentation is of no value to the customer. Regardless of the product quality and the processing quality, the medical product cannot be sold on the market if any part of this documentation is omitted. Sumitomo (SHI) Demag medical machine


Qualification files are signed and sent from the location where the machine order was fulfilled. For our machines, that is Germany or China. However, like most global organisations we are transitioning to digital files in alignment with production capabilities.


WHO SHOULD INPUT TO URS DOCUMENTATION AND SATS? All members of the production team who possess an in-depth knowledge of processing should provide the initial input. Ensuring the machine commissioned will produce medical components of the specified quality and integrity. Notably, the same people should not be used to conduct the Site Acceptance Tests. It is always deemed more robust if an impartial scientific or engineering based professional who makes no inherent assumptions about machine performance undertakes SATs. Our medical team can provide support and


guidance right up until the SAT. Once configured with the mould tooling, automation and other periphery equipment, the customer assumes overall responsibility for the production cell. At that point really everything should have been checked with regard to the material influences and how the moulding machine performs.


DO MACHINERY MANUFACTURERS HAVE A RESPONSIBILITY TO ‘RED FLAG’ IMPOSSIBLE PROCESSING REQUESTS? Absolutely. This is of the greatest value to customers. Unrealistic processing decisions should be challenged at the earliest phase by the sales team, drawing in expertise when required. This prevents lengthy delays to time-critical projects. Out of regulatory fear, people may submit a URS


request that is completely unattainable and frankly mostly unwarranted for the medical component being made. For example, the repercussions of asking for +/-5 micron tolerance in a one dimensional plastic part can increase costs tenfold or more. That is a challenging processing window, and unlikely justifiable. Realistically, the person requesting this has little comprehension of the time delay or cost ramifications, which inevitably passes down the chain. Bringing clarity to requests of this nature can


save medical manufacturers millions. With 15 globally trained and cross departmental medical experts, our team is confident intervening at the earliest phase to ensure any nonsensical requests when not critical to the performance of the end product, are scaled right back.


Sumitomo (SHI) Demag uk.sumitomo-shi-demag.eu


51


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82